“…It should, however, be underscored that the identity of the reducing agent remains to be clarified for several of the biological contexts involving LPMOs (described later). In vitro studies have shown that reduction can occur via reaction with a variety of molecules (Kracher et al ., 2016; Frommhagen et al ., 2018), including small organic reductants (Vaaje‐Kolstad et al ., 2010), redox enzyme partners (Phillips et al ., 2011; Garajova et al ., 2016; Kracher et al ., 2016; Várnai et al ., 2018; Momeni et al ., 2021), lignin and their compounds (Westereng et al ., 2015), or even photoactivated molecules (Bissaro et al ., 2016, 2020a; Cannella et al ., 2016). A more controversial aspect pertains to the nature of the biological cosubstrate bringing the oxygen atom necessary for hydroxylation of either the C1 or C4 carbon of the scissile glycosidic bond (Vaaje‐Kolstad et al ., 2010; Phillips et al ., 2011), and inducing cleavage of the polysaccharide chain (Beeson et al ., 2012; Wang et al ., 2018).…”